Macrophage Polarization: Decisions That Affect Health.

PubWeight™: 0.77‹?›

🔗 View Article (PMID 26962469)

Published in J Clin Cell Immunol on October 30, 2015

Authors

Charles D Mills1, Robert A Harris2, Klaus Ley3

Author Affiliations

1: BioMedical Consultants, Marine on St. Croix, MN 55047 USA.
2: Applied Immunology & Immunotherapy, Department of Clinical Neuroscience, Karolinska Institutet, CMM, Karolinska Hospital, Stockholm, Sweden.
3: La Jolla Institute for Allergy and Immunology, La Jolla, CA 92037 USA.

Articles cited by this

Exploring the full spectrum of macrophage activation. Nat Rev Immunol (2008) 26.08

The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol (2004) 19.38

THE IMMUNOLOGICAL BASIS OF ACQUIRED CELLULAR RESISTANCE. J Exp Med (1964) 13.28

Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation. J Exp Med (1992) 8.46

Nitric oxide: a cytotoxic activated macrophage effector molecule. Biochem Biophys Res Commun (1988) 8.17

Lymphokine control of in vivo immunoglobulin isotype selection. Annu Rev Immunol (1990) 7.93

Antigen-presenting function of the macrophage. Annu Rev Immunol (1984) 7.83

Macrophage activation and polarization: nomenclature and experimental guidelines. Immunity (2014) 7.26

Function of macrophages in antigen recognition by guinea pig T lymphocytes. II. Role of the macrophage in the regulation of genetic control of the immune response. J Exp Med (1973) 7.14

M-1/M-2 macrophages and the Th1/Th2 paradigm. J Immunol (2000) 6.61

Mechanisms of fibrosis: therapeutic translation for fibrotic disease. Nat Med (2012) 6.15

Heterogeneity of cytokine secretion patterns and functions of helper T cells. Adv Immunol (1989) 5.92

Biochemical and functional characterization of three activated macrophage populations. J Leukoc Biol (2006) 4.87

Functional plasticity of macrophages: reversible adaptation to changing microenvironments. J Leukoc Biol (2004) 4.05

Role of cytokines and CD4+ T-cell subsets in the regulation of parasite immunity and disease. Immunol Rev (1989) 3.21

M1 and M2 Macrophages: Oracles of Health and Disease. Crit Rev Immunol (2012) 2.49

Recent advances in arginine metabolism: roles and regulation of the arginases. Br J Pharmacol (2009) 2.24

Temporal expression of different pathways of 1-arginine metabolism in healing wounds. J Immunol (1990) 2.06

M1 and M2 macrophages: the chicken and the egg of immunity. J Innate Immun (2014) 2.06

Identification of a novel macrophage phenotype that develops in response to atherogenic phospholipids via Nrf2. Circ Res (2010) 2.04

Microenvironments in tuberculous granulomas are delineated by distinct populations of macrophage subsets and expression of nitric oxide synthase and arginase isoforms. J Immunol (2013) 1.62

Macrophage arginine metabolism to ornithine/urea or nitric oxide/citrulline: a life or death issue. Crit Rev Immunol (2001) 1.61

Eat, kill or die: when amoeba meets bacteria. Curr Opin Microbiol (2008) 1.56

The historical milestones in the understanding of leukocyte biology initiated by Elie Metchnikoff. J Leukoc Biol (2011) 1.54

Sequential Immune Responses: The Weapons of Immunity. J Innate Immun (2015) 1.47

CXC chemokine ligand 4 induces a unique transcriptome in monocyte-derived macrophages. J Immunol (2010) 1.41

Regulatory macrophages: setting the threshold for therapy. Eur J Immunol (2011) 1.40

Macrophage arginine metabolism and the inhibition or stimulation of cancer. J Immunol (1992) 1.35

Anatomy of a discovery: m1 and m2 macrophages. Front Immunol (2015) 1.06

The ancestry and cumulative evolution of immune reactions. Acta Biochim Pol (2010) 0.98

Macrophage: SHIP of Immunity. Front Immunol (2014) 0.92

A transcriptional perspective on human macrophage biology. Semin Immunol (2015) 0.87

Macrophages at the fork in the road to health or disease. Front Immunol (2015) 0.82

Spatial, Temporal, and Functional Aspects of Macrophages during "The Good, the Bad, and the Ugly" Phases of Inflammation. Front Immunol (2014) 0.80

The Activation of Complement and Its Role in the Pathogenesis of Thromboembolism. Semin Thromb Hemost (2015) 0.77